In 2023, female breast malignant neoplasms mortality in the US stood at approximately 22.8 deaths per hundred thousand women. The forecast for the period from 2024 to 2028 shows a gradual decline in the mortality rate, with yearly decreases in standardized rates observed at 0.9% to 1.4%. The compound annual growth rate (CAGR) over these five years suggests an overall decline in mortality of about 1.2% per year.
Future trends to watch for include improvements in early detection technologies, advancements in treatment options, and the impact of public health initiatives aimed at reducing cancer incidence and improving survival rates. Monitoring healthcare access disparities will also be crucial in understanding variations in mortality decline across different demographics.
